Diabetes mellitus, a chronic metabolic condition, poses numerous challenges
to global healthcare systems. Traditional pharmaceutical medications function
effectively, yet they generate problems together with adverse effects primarily affecting
patients who suffer from ongoing conditions. In 2014, World Health Organization data
shows that diabetes affects 8.5 percent of adults who are 18 years old and above. The
worldwide mortality rate from diabetes reached 1.5 million deaths in 2019, and 48% of
these deaths occurred among individuals under seventy years old. Blood glucose levels
that were too high were responsible for 20% of cardiovascular disease deaths, whereas
the total kidney disease deaths due to diabetes amounted to 460,000. Between 2000 and
2019, the death rates because of diabetes showed a 3% increase in every standard
measure. The review investigates three natural herbs, Gymnema Sylvestre, bitter melon
(Momordica charantia), and turmeric (Curcuma longa), for diabetes treatment while
evaluating the nanoscale formulation potential of these remedies. Research in
nanotechnology enables healthcare providers to enhance herbal solutions at the nano
level to achieve better bioavailability with targeted delivery systems and sustained
release mechanisms as essential elements for optimizing diabetes care treatment. The
chapter analyzes how herbal products integrated with nanoformulations work as part of
diabetes care plans through discussions of improved therapeutic results regarding drug
absorption rates while addressing stability and toxicity levels. The discussion ends with
guidance on implementing herbal nano solutions within complete diabetes care plans
and approaches combining personalized treatment with multidisciplinary teamwork for
optimal patient results.
Keywords: Bioavailability, Diabetes management, Herbal nanomedicine, Nanoformulations, Personalized medicine.
